Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques

Journal of Pharmaceutical Sciences

Volumn 97, Issue 2, 2008, Pages 764-774

  Mahler, Hanns Christian ^a   Printz, Miriam ^a   Kopf, Robert ^a   Schuller, Rudolf ^a   Müller, Robert ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Biotechnology; Critical micelle concentration; Filtration; Micelles; Polysorbate; Protein formulation; Proteins; Surfactants; Tween; Ultrafiltration

Indexed keywords

POLYSORBATE 20;

ARTICLE; ARTIFICIAL MEMBRANE; BIOTECHNOLOGY; DIALYSIS; DRUG FORMULATION; DRUG PURIFICATION; MICELLE; ULTRAFILTRATION;

EID: 39749100132     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21029     Document Type: Article

References (53)

1. Pavlou AK, Belsey MJ. 2005. The therapeutic antibodies market to 2008. Eur J Pharm Biopharm 59:389-396.
2. Carpenter JF, Kendrick BS, Chang BS, Manning MC, Randolph TW. 1999. Inhibition of stress-induced aggregation of protein therapeutics. Methods Enzymol 309:236-255.
3. Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 10:307-377.
4. Wang W. 2005. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289:1-30.
5. Patro SY, Freund E, Chang BS. 2002. Protein formulation and fill-finish operations. Biotechnol Annu Rev 8:55-84.
6. Carpenter JL, Chang BS. 1996. Lyophilization of protein pharmaceuticals. In: Avis KF, Wu VL, editors. Biotechnology and biopharmaceutical manufacturing, processing, and preservation, 1st edition. Buffalo Grove, IL: Interpharm CRC. p 199-264.
7. Costantino HR, Langer R, Klibanov AM. 1994. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J Pharm Sci 83:1662-1669.
8. Costantino HR, Langer R, Klibanov AM. 1994. Moisture-induced aggregation of lyophilized insulin. Pharm Res 11:21-29.
9. Schellekens H. 2002. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev Drug Discov 1:457-462.
10. Jones LS, Bam NB, Randolph TW. 1997. Surfactant-stabilized protein formulations: A review of protein-surfactant interactions and novel analytical methodologies. In: Shahrokh Z, Cleland JL, Shire SJ, editors. Therapeutic proteins and protein formulation and delivery, 1st edition. Washington, DC: An American Chemical Society Publication. p 206-222.
11. Randolph TW, Jones LS. 2002. Surfactant-protein interactions. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations - Theory and practice, 1st edition. New York: Kluwer Academic/Plenum Publishers. p 159-175.
12. Porter MR. 1994. Handbook of surfactants. 2nd edition. London: Blackie Academic and Professional.
13. Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20:1325-1336.
14. Treuheit MJ, Kosky AA, Brems DN. 2002. Inverse relationship of protein concentration and aggregation. Pharm Res 19:511-516.
15. Mahler HC, Muller R, Friess W, Delille A, Matheus S. 2005. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur J Pharm Biopharm 59:407-417.
16. Katakam M, Bell LN, Banga AK. 1995. Effect of surfactants on the physical stability of recombinant human growth hormone. J Pharm Sci 84:713-716.
17. Chang BS, Kendrick BS, Carpenter JF. 1996. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J Pharm Sci 85:1325-1330.
18. Kreilgaard L, Jones LS, Randolph TW, Frokjaer S, Flink JM, Manning MC, Carpenter JF. 1998. Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. J Pharm Sci 87:1597-1603.
19. Bam NB, Randolph TW, Cleland JL. 1995. Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm Res 12:2-11.
20. Bam NB, Cleland JL, Randolph TW. 1996. Molten globule intermediate of recombinant human growth hormone: Stabilization with surfactants. Biotechnol Prog 12:801-809.
21. Tandon S, Horowitz PM. 1987. Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effects of the concentration and type of detergent. J Biol Chem 262:4486-4491.
22. Timasheff SN. 1993. The control of protein stability and association by weak interactions with water: how do solvents affect these processes? Annu Rev Biophys Biomol Struct 22:67-97.
23. Charman SA, Mason KL, Charman WN. 1993. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm Res 10:954-962.
24. Bam NB, Cleland JL, Yang J, Manning MC, Carpenter JF, Kelley RF, Randolph TW. 1998. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci 87:1554-1559.
25. Chou DK, Krishnamurthy R, Randolph TW, Carpenter JF, Manning MC. 2005. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. J Pharm Sci 94:1368-1381.
26. Kerwin BA, Heller MC, Levin SH, Randolph TW. 1998. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin. J Pharm Sci 87:1062-1068.
27. Vidanovic D, Milic Askrabic J, Stankovic M, Poprzen V. 2003. Effects of nonionic surfactants on the physical stability of immunoglobulin G in aqueous solution during mechanical agitation. Pharmazie 58:399-404.
28. Anchordoquy TJ, Izutsu KI, Randolph TW, Carpenter JF. 2001. Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying. Arch Biochem Biophys 390:35-41.
29. Heller MC, Carpenter JF, Randolph TW. 1999. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol Bioeng 63:166-174.
30. Hillgren A, Lindgren J, Alden M. 2002. Protection mechanism of Tween 80 during freeze-thawing of a model protein, LDH. Int J Pharm 237:57-69.
31. Carpenter JF, Arakawa T, Crowe JH. 1992. Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Dev Biol Stand 74:225-238 discussion 238-229.
32. Jones LS, Randolph TW, Kohnert U, Papadimitriou A, Winter G, Hagmann ML, Manning MC, Carpenter JF. 2001. The effects of Tween 20 and sucrose on the stability of anti-L-selectin during lyophilization and reconstitution. J Pharm Sci 90:1466-1477.
33. Kreilgaard L, Frokjaer S, Flink JM, Randolph TW, Carpenter JF. 1998. Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. Arch Biochem Biophys 360:121-134.
34. Duncan MR, Lee JM, Warchol MP. 1995. Influence of surfactants upon protein/peptide adsorption to glass and polypropylene. Int J Pharmaceut 120:179-188.
35. Tiefenbach KJ, Durchschlag H, Jaenicke R. 1999. Spectroscopic and hydrodynamic investigations of nonionic and zwitterionic detergents. Progr Colloid Polym Sci 113:135-141.
36. Rowe RC. 2005. Handbook of pharmaceutical excipients, 5th edition. Washington, DC: APhA Publications.
37. Wan LS, Lee PF. 1974. CMC of polysorbates. J Pharm Sci 63:136-137.
38. Helenius A, McCaslin DR, Fries E, Tanford C. 1979. Properties of detergents. In: Fleischer S, Packer L, editor. Biomembranes Part G: Bioenergetics: Biogenesis of mitochondria, organization, and transport, Vol. 56, 1st edition. London: Academic Press. p 734-749.
39. Neugebauer JM. 1990. Detergents: An overview. In: Deutscher MP, editor. Guide to protein purification, Vol. 182, 1st edition. London: Academic Press. p 239-253.
40. Helenius A, Simons K. 1975. Solubilization of membranes by detergents. Biochim Biophys Acta: Rev Biomembr 415:29-79.
41. Chang BS, Hershenson S. 2002. Practical approaches to protein formulation development. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations - Theory and practice, 1st edition. New York: Kluwer Academic/Plenum Publisher. p 203.
42. Nayar R, Manning MC. 2002. High throughput formulation: Strategies for rapid development of stable protein products. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations - Theory and practice. 1st edition. New York: Kluwer Academic/Plenum Publishers. p 203.
43. Kurnik RT, Yu AW, Blank GS, Burton AR, Smith D, Athalye AM, van Reis R. 1995. Buffer exchange using size exclusion chromatography, countercurrent dialysis, and tangential flow filtration: Models, development, and industrial application. Biotechnol Bioeng 45:149-157.
44. Schratter P. 2004. Purification and concentration by ultrafiltration. Methods Mol Biol 244:101-116.
45. Pohl T. 1990. Concentration of proteins and removal of solutes. Methods in enzymology. In: Deutscher MP, editor. Guide to protein purification, Vol. 182, 1st edition. New York: Academic Press. p 68-83.
46. van Reis R, Zydney A. 2001. Membrane separations in biotechnology. Curr Opin Biotechnol 12: 208-211.
47. Hjelmeland LM. 1990. Removal of detergents from membrane proteins. In: Deutscher MP, editor. Guide to protein purification. 1st edition. London: Academic Press. p 277-282.
48. Furth AJ, Bolton H, Potter J, Priddle JD. 1984. Separating detergent from proteins. In: Jakoby WB, editor. Part C: Enzyme purification and related techniques. 1st edition. London: Academic Press. p 318-328.
49. Ohlendieck K. 2004. Removal of detergent from protein fractions. Methods Mol Biol 244:295-300.
50. 2007. Physician's desk reference, 61st edition. Montvale, NJ: Thomson PDR.
51. Sundaram S. 1998. Protein adsorption in microporous membrane filtration. In: Meltzer TH, Jornitz MW, editors. Filtration in the biophamraceutical industry. 1st edition. New York: Marcel Dekker. p 533-575.
52. 1998. Technical Report No. 26 - Sterilizing filtration of liquids. PDA J Pharm Sci Technol 52:1-31.
53. Miller R, Fainerman VB, Makievski AV, Kragel J, Grigoriev DO, Kazakov VN, Sinyachenko OV. 2000. Dynamics of protein and mixed protein/surfactant adsorption layers at the water/fluid interface. Adv Colloid Interf Sci 86:39-82.